EXHIBIT 10.4Management Agreement • March 15th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Washington
EXHIBIT 10.8 SECURITIES PURCHASE AGREEMENT DATED AS OF OCTOBER 23, 2000 BY AND BETWEEN PHAGE THERAPEUTICS INTERNATIONAL INC. AS THE ISSUER,Securities Purchase Agreement • March 15th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Florida
EXHIBIT 10.6 CONSULTING AGREEMENT Consulting Agreement THIS CONSULTING AGREEMENT, having an effective date of October 9, 2000 is made between Deirdre (Dee) E. Sweeney, doing business as Sweeney Regulatory Consulting (herein referred to as...Consulting Agreement • March 15th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research
Exhibit 10.2 CONFIDENTIAL DISCLOSURE AGREEMENT --------------------------------- This agreement (the "Agreement") is made effective on this date, ____________, by and between Phage Therapeutics, Inc., 19017 - 120th Avenue NE, Suite 102, Bothel, WA...Confidential Disclosure Agreement • March 15th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research • Washington
EXHIBIT 10.1 ------------ Advisory Agreements for John J. Majnarich and Michael C. Maloney ADVISORY AGREEMENT Phage Therapeutics, Inc. ("PhageTx" or the "Company") desires to engage the advisory services ("Services") of John J. Majnarich, PhD, as an...Advisory Agreement • March 15th, 2001 • Phage Therapeutics International Inc • Services-commercial physical & biological research
